Connecticut-based Health Media Network (HMN) and Florida-based Digital Blue Dog (DBD) have signed an agreement to exclusively represent DBD's Oncology Network, creating the largest Oncology specific and patient-centric point-of-care network in the U.S.
The two companies will still maintain operational independence while HMN will exclusively represent the combined network of nearly 15,000 high prescription writers.
"Digital Blue Dog's Oncology Network brings some of the finest world-class cancer treatment doctors to the HMN Oncology Network," said Christopher Culver, CEO of Health Media Network. "These oncologists are community based practices, considered some of the best in this clinical category."
"This is an exciting and innovative opportunity for HMN and consistent with our growth strategy to engage and motivate patients to take action with their Oncology care providers," stated Larry Newman, HMN's Chief Operating Officer. "Digital Blue Dog's Network is a natural addition to our core point-of-care Oncology operations and offers advertisers of DTC and OTC brands a new, unique and profitable opportunity to reach the consumer with information that engages, educates and motivates them to have more meaningful discussions with their care providers."
"Our goal is to build a world-class, hyper-focused Oncology Network providing relevant, engaging, and educational patient content," said John Boyle, CEO of Digital Blue Dog. "In an era of increasing number of patients and decreasing specialists to serve them, our network is critical in disseminating Oncology-specific information to patients as well as general health and well-being information."